<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29589" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Stunned Myocardium (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Parajuli</surname>
            <given-names>Priyanka</given-names>
          </name>
          <aff>Southern Illinois University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Priyanka Parajuli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29589.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The myocardium is composed of cardiac muscle fibers. The contraction of these myocardial fibers leads to the contraction of the heart. Prolonged severe reduction of coronary blood flow can seize myocardial contractility in an irreversible fashion as a result of myocardial necrosis.<xref ref-type="bibr" rid="article-29589.r1">[1]</xref>&#x000a0;However, the myocardium can be salvaged with early coronary reperfusion. Nonetheless, the viable reperfused myocardium might not return to contracting properly immediately following reperfusion. The subsequent prolonged but transient postischemic dysfunction after reperfusion is known as the stunned myocardium.<xref ref-type="bibr" rid="article-29589.r2">[2]</xref>&#x000a0;Similarly, neurologic pathologies can also lead to stunning of the myocardium, and the phenomenon is collectively called neurogenic stunned myocardium.<xref ref-type="bibr" rid="article-29589.r3">[3]</xref></p>
      </sec>
      <sec id="article-29589.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Coronary hypoperfusion as a consequence of coronary artery disease can lead to myocardial ischemia or myocardial infarction.&#x000a0;Stunned myocardium is viable myocardium salvaged by coronary reperfusion that exhibits prolonged postischemic dysfunction after reperfusion.<xref ref-type="bibr" rid="article-29589.r4">[4]</xref>&#x000a0;Similarly, newer studies have revealed a few more causes of stunned myocardium, including stress cardiomyopathy (Takotsubo), neurogenic stunned myocardium, and left ventricular (LV) abnormalities associated with dialysis.<xref ref-type="bibr" rid="article-29589.r5">[5]</xref>&#x000a0;Some causes of neurogenic myocardium discussed in the literature include stroke, subarachnoid hemorrhage, metastatic brain tumors, seizures, Guillain-Barr&#x000e9; syndrome, reversible posterior leukoencephalopathy syndrome, and meningioma.<xref ref-type="bibr" rid="article-29589.r6">[6]</xref><xref ref-type="bibr" rid="article-29589.r7">[7]</xref></p>
      </sec>
      <sec id="article-29589.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The exact incidence and prevalence of stunned myocardium are not appreciated as it is a transient process, and routine diagnostics for evaluation of stunned myocardium are not recommended. However, newer studies reveal that patients from all age groups, including the pediatric population on hemodialysis (HD), can develop myocardial stunning.<xref ref-type="bibr" rid="article-29589.r8">[8]</xref><xref ref-type="bibr" rid="article-29589.r9">[9]</xref>&#x000a0;According to some studies, there is a 5 to 26 times increased risk of developing stunned myocardium in patients receiving standard HD sessions with the removal of 1 L to 2 L of fluids.<xref ref-type="bibr" rid="article-29589.r10">[10]</xref><xref ref-type="bibr" rid="article-29589.r9">[9]</xref>&#x000a0;Similarly, a Polish study with a cohort of 120 patients with acute coronary syndrome for the first time revealed one in every four patients had neurogenic stunned myocardium, as evidenced by regional ventricular wall dysfunction remote to the ischemic territory.<xref ref-type="bibr" rid="article-29589.r11">[11]</xref>&#x000a0;Future studies are warranted to&#x000a0;evaluate the occurrence of&#x000a0;stunned myocardium in various populations.</p>
      </sec>
      <sec id="article-29589.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The principal pathology of stunned myocardium is coronary hypoperfusion leading to hypoperfused myocardium. Generally, transient coronary hypoperfusion due to overactive sympathetic response, overproduction of catecholamine and endothelin, and cardiac inflammation can individually or collectively lead to stunning of the myocardium.<xref ref-type="bibr" rid="article-29589.r12">[12]</xref>&#x000a0;Moreover, multiple mechanisms involving changes at a cellular level and autoregulatory phenomena have been reported to be involved in myocardial stunning. Some of the mechanisms are described below.</p>
        <p>At a cellular level, abnormal energy utilization, production of oxygen free radicals, and abnormal calcium reflux seem to play a role&#x000a0;in the development of stunned myocardium.&#x000a0;</p>
        <p>1. Abnormal energy utilization: Animal studies have revealed a prolonged hypoperfusion state of about 15 minutes, followed by vascular reperfusion leading to a disturbance in energy utilization in the hypoperfused organ. This disruption in the myocardium can potentially lead to a decreased utilization of creatinine kinase (CK), an enzyme involved in the energy generation required for cardiac contractility.<xref ref-type="bibr" rid="article-29589.r2">[2]</xref><xref ref-type="bibr" rid="article-29589.r13">[13]</xref></p>
        <p>2. Production of oxygen-derived free radicals and abnormal calcium flux: During the first few minutes of myocardial reperfusion, free radicals are generated that lead to reperfusion injury.&#x000a0;<xref ref-type="bibr" rid="article-29589.r14">[14]</xref> The number of free radicals formed decreases as the number of collateral circulations around the ischemic coronaries increases during the ischemic event. Similarly, as the duration of the ischemic event prolongs, the number of free radicals formed also increases.<xref ref-type="bibr" rid="article-29589.r14">[14]</xref>&#x000a0;Duration and severity of ischemia, therefore, are major contributory factors to the degree of stunned myocardium.<xref ref-type="bibr" rid="article-29589.r15">[15]</xref>&#x000a0;Similarly, calcium levels start to elevate within 1 to 10 minutes of ischemia. Calcium level stays elevated even after reperfusion and precludes normal cardiac contractility.<xref ref-type="bibr" rid="article-29589.r16">[16]</xref><xref ref-type="bibr" rid="article-29589.r17">[17]</xref>&#x000a0;It is also believed that free radicals, along with elevated calcium generated during ischemic events and early reperfusion, impair the proteins of myocardial contractile machinery or sarcoplasmic reticulum, subsequently leading to myocardial stunning.<xref ref-type="bibr" rid="article-29589.r18">[18]</xref></p>
        <p>Similarly, there is some auto-regulatory phenomenon that plays a role in the development of a stunned myocardium as well. Perfusion-contraction mismatch that occurs in hypoperfused myocardium reduces the contractile function of the myocardial fibers. Injured myocardium that undergoes reperfusion can present transiently as segmental wall motion abnormalities with ventricular dysfunction.</p>
        <p>Further, neurologic events such as hemorrhages, strokes, and seizures can cause myocardial injury leading to neurogenic stunned myocardium with features including elevated troponin, EKG changes, and left ventricular dysfunction. The pathophysiology behind stunned myocardium in these conditions is presumed to be sympathetic surge and autonomic dysregulation.<xref ref-type="bibr" rid="article-29589.r19">[19]</xref></p>
      </sec>
      <sec id="article-29589.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The signs and symptoms manifested in patients with stunned myocardium are a result of underlying coexisting pathologies, including coronary artery disease and ischemic heart disease. When ischemic myocardial tissue undergoes reperfusion, most of the viable myocytes regain their contractile function, but some continue to have depressed contractility transiently. Since the stunning of the myocardium is a pathophysiological response to myocardial reperfusion, the evaluation of patients with stunned myocardium should focus on the history of present illness in these patients. Emphasis should be given to symptoms of chest pain at rest or exertion, past medical history, social and family history that includes the risk factors for coronary artery disease, diabetes mellitus, and hypertension.</p>
      </sec>
      <sec id="article-29589.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The dysfunction of myocardial contractility, followed by myocardial ischemia and reperfusion, eventually regains full functionality. Nonetheless, stunned myocardium can be assessed using various modalities to evaluate for myocardial viability, including transthoracic echocardiography (TTE), dobutamine stress echocardiography (DSE), myocardial contrast echocardiography (MCE), single-photon emission computed tomography (SPECT), and positron emission tomography (PET).</p>
        <p>
<bold>Transthoracic Echocardiography (TTE)</bold>
</p>
        <p>Myocardial necrosis is associated with myocardial thinning; preserved end-diastolic wall thickness (EDWT) may provide a simple index of myocardial viability that can be assessed with a resting echocardiogram. EDWT less than or equal to 0.6 cm exclude myocardial viability.<xref ref-type="bibr" rid="article-29589.r20">[20]</xref></p>
        <p>
<bold>Dobutamine Stress Echocardiography (DSE)</bold>
</p>
        <p>It can help assess myocardial contractile reserve. A low dose of dobutamine can increase contractility of viable dysfunctional segments, whereas a higher dose can either improve or diminish myocardial contractility of the viable myocardial segments. Scarred tissues do not demonstrate such a phenomenon with either dose of dobutamine.<xref ref-type="bibr" rid="article-29589.r21">[21]</xref></p>
        <p>
<bold>Myocardial Contrast Echocardiography (MCE)</bold>
</p>
        <p>This diagnostic tool has a high sensitivity for diagnosing myocardial viability and is good at predicting the functional recovery of myocardial tissues after revascularization. The contrast used in MCE is acoustically active gas-filled microbubbles. These microbubbles remain in the intravascular space and can help delineate the left ventricular border. Contrast in the myocardial segments reveals viable myocardial tissues, whereas lack of contrast augmentation reflects nonviable myocardium.<xref ref-type="bibr" rid="article-29589.r21">[21]</xref>&#x000a0;</p>
        <p>
<bold>Single-photon Emission Computed Tomography (SPECT)</bold>
</p>
        <p>The most commonly used tracers for SPECT include thallium-201 (Tl) and technetium-99m (Tc) &#x02013;labeled compounds. Myocardial uptake of Tl 4 to 24 hours after injection reflects the integrity of sarcolemma, revealing tissue viability.<xref ref-type="bibr" rid="article-29589.r22">[22]</xref>&#x000a0;Technetium-99m (Tc) labeled compounds are lipophilic molecules. Myocardial uptake of these compounds can provide information on both myocardial perfusion and viability.<xref ref-type="bibr" rid="article-29589.r23">[23]</xref></p>
        <p>
<bold>Positron Emission Tomography (PET)</bold>
</p>
        <p>PET evaluates cellular metabolism, thereby assessing the cellular integrity of the myocytes. The most commonly used tracer for a PET scan is FDG (fluorodeoxyglucose). Uptake of FDG reflects viable tissue, whereas the absence of tracer uptake is a reflection of scar tissue.<xref ref-type="bibr" rid="article-29589.r24">[24]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-29589.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no guidelines-based treatment available for stunned myocardium. At present, no known medical therapy is available that can hasten the recovery of stunned myocardium. Since myocardial stunning is a transient phenomenon and myocardium regains full functionality after some time following reperfusion, the focus of care and medical therapy in patients with stunned myocardium lies in the treatment of underlying ischemic tissue. Ionotropic agents can temporarily assist in cases of severe myocardial dysfunction.</p>
      </sec>
      <sec id="article-29589.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Hibernating myocardium: When myocardial and left ventricular function is persistently impaired due to chronic reduction in coronary blood flow, the myocardium adapts to a low flow state called the hibernating myocardium. Myocardial tissue that undergoes hibernation has reduced contractility due to prolonged poor perfusion but is viable and can recover full functionality with revascularization. The important difference between the two phenomena is in the level of blood flow to the tissue. Stunned myocardium has, by definition, been reperfused and the ischemia relieved; however, the function remains depressed for hours, days, or even weeks afterward. In contrast, hibernating myocardium represents the persistent dysfunction of viable myocytes only during a period of reduced blood flow; when blood flow is restored, ventricular function improves. Imaging techniques used to determine myocardial stunning can also help assess hibernating myocardium.</p>
      </sec>
      <sec id="article-29589.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Stunned myocardium is a temporary state, and reperfused myocytes will eventually regain their full contractile function.</p>
      </sec>
      <sec id="article-29589.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Repeated episodes of myocardial stunning can lead to a gradual worsening of the myocardial contractile dysfunction.</p>
      </sec>
      <sec id="article-29589.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Stunning of the myocardium can coexist with other severe cardiac diseases such as coronary artery diseases and ischemic heart diseases. Similarly, occasionally myocardium can be stunned in patients with a neurological condition such as subarachnoid hemorrhage and people undergoing dialysis. There is no treatment for stunned myocardium. Therefore, patients diagnosed with stunned myocardium or at risk for developing the disease should be made aware of the underlying medical conditions and managed accordingly.</p>
      </sec>
      <sec id="article-29589.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Stunned myocardium is a temporary state, and routine diagnostic for its evaluation is not recommended. There is no therapeutic management geared towards its management. Since stunned myocardium occurs mostly after reperfusion of ischemic myocardium, the condition is best managed by an interprofessional health care team approach, including doctors, nurses, pharmacists, physiotherapists, dietitians, physical trainers, and psychologists.</p>
        <p>Asymptomatic patients should continue to get annual exams, and underlying risk factors should be treated appropriately. Patients with underlying hypertension, heart failure, coronary artery diseases need strict blood pressure control, medical management, and lifestyle modification. Patients who undergo reperfusion therapy require antiplatelet therapy to avoid any cardiovascular thrombotic events. Pharmacists can help ensure patients get all their medications in a timely fashion. They can also recommend medication selection, dosing, and reconciliation to avoid any drug interactions. Pharmacists can also help report any adverse drug reaction to the health care team and assist in subsequent medication changes and patient counseling. Nurses are an integral part of patient care, especially while patients remain inpatient. Their role is integral in emphasizing and monitoring medication compliance and providing counseling. A fully collaborative, interprofessional team approach can help achieve optimal results in patients with stunned myocardium. [Level 5]</p>
      </sec>
      <sec id="article-29589.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29589&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29589">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29589/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29589">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29589.s14">
        <title>References</title>
        <ref id="article-29589.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heusch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Characterization of hibernating and stunned myocardium.</article-title>
            <source>Eur Heart J</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>18 Suppl D</volume>
            <fpage>D102</fpage>
            <page-range>D102-10</page-range>
            <pub-id pub-id-type="pmid">9183618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conti</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>The stunned and hibernating myocardium: a brief review.</article-title>
            <source>Clin Cardiol</source>
            <year>1991</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>708</fpage>
            <page-range>708-12</page-range>
            <pub-id pub-id-type="pmid">1742904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Neurogenic stunned myocardium in subarachnoid hemorrhage.</article-title>
            <source>J Crit Care</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>38</volume>
            <fpage>27</fpage>
            <page-range>27-34</page-range>
            <pub-id pub-id-type="pmid">27837689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahimtoola</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>The hibernating myocardium.</article-title>
            <source>Am Heart J</source>
            <year>1989</year>
            <month>Jan</month>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>211</fpage>
            <page-range>211-21</page-range>
            <pub-id pub-id-type="pmid">2783527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kloner</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later?</article-title>
            <source>J Am Heart Assoc</source>
            <year>2020</year>
            <month>Feb</month>
            <day>04</day>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>e015502</fpage>
            <pub-id pub-id-type="pmid">32013699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goyal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bharadwaj</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Neurogenic Pulmonary Edema and Stunned Myocardium in a Patient With Meningioma: A Heart-Brain Cross Talk.</article-title>
            <source>J Neurosurg Anesthesiol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>264</fpage>
            <page-range>264-265</page-range>
            <pub-id pub-id-type="pmid">29432276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magid-Bernstein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Al-Mufti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Merkler</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Claassen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Unexpected Rapid Improvement and Neurogenic Stunned Myocardium in a Patient With Acute Motor Axonal Neuropathy: A Case Report and Literature Review.</article-title>
            <source>J Clin Neuromuscul Dis</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>135</fpage>
            <page-range>135-41</page-range>
            <pub-id pub-id-type="pmid">26905914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hothi</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Rees</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>790</fpage>
            <page-range>790-7</page-range>
            <pub-id pub-id-type="pmid">19339406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zuidema</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Dellsperger</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Myocardial Stunning with Hemodialysis: Clinical Challenges of the Cardiorenal Patient.</article-title>
            <source>Cardiorenal Med</source>
            <year>2012</year>
            <month>May</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-133</page-range>
            <pub-id pub-id-type="pmid">22851961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burton</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Jefferies</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Selby</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Hemodialysis-induced cardiac injury: determinants and associated outcomes.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2009</year>
            <month>May</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>914</fpage>
            <page-range>914-20</page-range>
            <pub-id pub-id-type="pmid">19357245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iwaszczuk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ko&#x00142;odziejczyk</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kruczek</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Drabik</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>P&#x00142;azak</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Komar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Podolec</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Musia&#x00142;ek</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Ischemic Versus Non-Ischemic (Neurogenic) Myocardial Contractility Impairment in Acute Coronary Syndromes: Prevalence and Impact on Left Ventricular Systolic Function Recovery.</article-title>
            <source>Med Sci Monit</source>
            <year>2018</year>
            <month>Jun</month>
            <day>02</day>
            <volume>24</volume>
            <fpage>3693</fpage>
            <page-range>3693-3701</page-range>
            <pub-id pub-id-type="pmid">29858549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guaricci</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Bulzis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pontone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scicchitano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carbonara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rabbat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Santis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ciccone</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Current interpretation of myocardial stunning.</article-title>
            <source>Trends Cardiovasc Med</source>
            <year>2018</year>
            <month>May</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>263</fpage>
            <page-range>263-271</page-range>
            <pub-id pub-id-type="pmid">29221768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greenfield</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Swain</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Disruption of myofibrillar energy use: dual mechanisms that may contribute to postischemic dysfunction in stunned myocardium.</article-title>
            <source>Circ Res</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>283</fpage>
            <page-range>283-9</page-range>
            <pub-id pub-id-type="pmid">2952365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McCay</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <article-title>Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial "stunning".</article-title>
            <source>Free Radic Res Commun</source>
            <year>1990</year>
            <volume>9</volume>
            <issue>3-6</issue>
            <fpage>169</fpage>
            <page-range>169-80</page-range>
            <pub-id pub-id-type="pmid">2167254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Common methodological problems and artifacts associated with studies of myocardial stunning in vivo.</article-title>
            <source>Basic Res Cardiol</source>
            <year>1995</year>
            <season>Jul-Aug</season>
            <volume>90</volume>
            <issue>4</issue>
            <fpage>257</fpage>
            <page-range>257-62</page-range>
            <pub-id pub-id-type="pmid">8534240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marban</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kitakaze</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koretsune</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yue</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Chacko</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Pike</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Quantification of [Ca2+]i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion.</article-title>
            <source>Circ Res</source>
            <year>1990</year>
            <month>May</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>1255</fpage>
            <page-range>1255-67</page-range>
            <pub-id pub-id-type="pmid">2110515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Acidemia and hypernatremia enhance postischemic recovery of excitation-contraction coupling.</article-title>
            <source>Circ Res</source>
            <year>1994</year>
            <month>Jun</month>
            <volume>74</volume>
            <issue>6</issue>
            <fpage>1197</fpage>
            <page-range>1197-209</page-range>
            <pub-id pub-id-type="pmid">8187286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Atar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Marban</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Role of troponin I proteolysis in the pathogenesis of stunned myocardium.</article-title>
            <source>Circ Res</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>393</fpage>
            <page-range>393-9</page-range>
            <pub-id pub-id-type="pmid">9048660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biso</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wongrakpanich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yadlapati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kishlyansky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Figueredo</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>A Review of Neurogenic Stunned Myocardium.</article-title>
            <source>Cardiovasc Psychiatry Neurol</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>5842182</fpage>
            <pub-id pub-id-type="pmid">28875040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cwajg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cwajg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nagueh</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>ZX</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Olmos</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Quinones</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Verani</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Winters</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Zoghbi</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>1152</fpage>
            <page-range>1152-61</page-range>
            <pub-id pub-id-type="pmid">10758955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camici</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Rimoldi</surname>
                <given-names>OE</given-names>
              </name>
            </person-group>
            <article-title>Stunning, hibernation, and assessment of myocardial viability.</article-title>
            <source>Circulation</source>
            <year>2008</year>
            <month>Jan</month>
            <day>01</day>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-14</page-range>
            <pub-id pub-id-type="pmid">18172050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sciagr&#x000e0;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sestini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bolognese</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cerisano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Buonamici</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pupi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparison of dobutamine echocardiography and 99mTc-sestamibi tomography for prediction of left ventricular ejection fraction outcome after acute myocardial infarction treated with successful primary coronary angioplasty.</article-title>
            <source>J Nucl Med</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-14</page-range>
            <pub-id pub-id-type="pmid">11801696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sciagr&#x000e0;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pellegri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pupi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bolognese</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bisi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carnovale</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Santoro</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>739</fpage>
            <page-range>739-45</page-range>
            <pub-id pub-id-type="pmid">10987593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29589.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knuuti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bengel</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Positron emission tomography and molecular imaging.</article-title>
            <source>Heart</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>360</fpage>
            <page-range>360-7</page-range>
            <pub-id pub-id-type="pmid">18276820</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
